Finance

Lists
4588:TYO
Oncolys Biopharma Inc
¥6,290.00
-0.94%
(-60.00) 1D
Oct 8, 9:11:02 AM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4588...
Open
¥6,310
High
¥6,550
Low
¥6,220
Mkt. cap
176.46B
Avg. vol.
1.94M
Volume
406.70K
52-wk high
¥7,020
52-wk low
¥668
EPS
-¥54
Shares outstanding
13.14M
No. of employees
45
Open
¥6,310
High
¥6,550
Low
¥6,220
Mkt. cap
176.46B
Avg. vol.
1.94M
Volume
406.70K
52-wk high
¥7,020
52-wk low
¥668
EPS
-¥54
Shares outstanding
13.14M
No. of employees
45
News stories
From web sources and news partners
About Oncolys Biopharma Inc
CEO-
Employees45
FoundedMar 18, 2004
Headquarters-
SectorBiotechnology
Websiteoncolys.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Mar 2026
Jun 2026
Revenue
28.55M
-
3.09M
500.00M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
510.47M
303.94M
423.81M
846.89M
Operating expense
511.47M
305.01M
423.81M
849.46M
Total operating expenses
511.47M
305.01M
423.81M
849.46M
Operating income
-482.92M
-305.01M
-420.72M
-349.46M
Other non operating income
13.00K
-8.69M
-2.14M
-62.00K
EBT including unusual items
-500.86M
-302.92M
-413.36M
-347.24M
EBT excluding unusual items
-500.86M
-302.92M
-413.36M
-347.24M
Income tax expense
713.00K
891.00K
1.12M
430.00K
Effective tax rate
-0.14%
-0.29%
-0.27%
-0.12%
Other operating expenses
-
-
-
-
Net income
-501.58M
-303.81M
-414.48M
-347.67M
Net profit margin
-1,757.08%
-
-13,413.66%
-69.53%
Earnings per share
-
-
-
-
Interest and investment income
479.00K
1.52M
3.04M
199.00K
Interest expense
-1.20M
-1.51M
-2.99M
-5.85M
Net interest expenses
-725.00K
10.00K
58.00K
-5.65M
Depreciation and amortization charges
-
-
-
-
EBITDA
-482.90M
-304.80M
-420.71M
-349.42M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps